RxSight, Inc. (RXST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 429.05M |
| Enterprise Value | 420.14M |
| P/E Ratio | -4.19 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 1.54 |
| Price/Book Ratio | 0.73 |
| Enterprise/Revenue | 1.48 |
| Enterprise/EBITDA | -4.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.37 |
| Operating Margin | -0.43 |
AD
Management Effectiveness
| Return On Assets | -0.15 |
| Return On Equity | -0.17 |
Income Statement
| Revenue | 134.48M |
| Revenue/Share | 3.09 |
| Gross Profit | 103.01M |
| EBITDA | -38.84M |
| Net Income | -38.94M |
| Diluted EPS | -0.95 |
Balance Sheet
| Total Cash | 217.88M |
| Total Cash/Share | 5.27 |
| Total Debt | 10.83M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 10.2 |
| Book Value Per Share | 6.47 |
Price History
| 52-Week Change | -65.07 |
| 52-Week High | 14.25 |
| 52-Week Low | 4.48 |
| Moving Average 50 Days | 6.09 |
| Moving Average 200 Days | 8.36 |
Statistics
| Average Volume | 809,503 |
| Shares Outstanding | 41.4M |
| % Held by Institutions | 92.76 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
